ARTICLE | Clinical News
IbuprofenER regulatory update
June 20, 2005 7:00 AM UTC
DDD will need an additional 9 months to submit an NDA for its extended-release formulation of ibuprofen to treat pain. The company now expects the submission to occur in mid-2006. ...